X4 PHARMACEUTICALS, INC Payments to Acquire Productive Assets
X4 PHARMACEUTICALS, INC (XFOR) reported Payments to Acquire Productive Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-03-17
- X4 PHARMACEUTICALS, INC payments to acquire productive assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- X4 PHARMACEUTICALS, INC payments to acquire productive assets for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- X4 PHARMACEUTICALS, INC payments to acquire productive assets for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- X4 PHARMACEUTICALS, INC payments to acquire productive assets for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- X4 PHARMACEUTICALS, INC payments to acquire productive assets for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- X4 PHARMACEUTICALS, INC payments to acquire productive assets for fiscal 2024 was $326.00K, a 443.33% increase from fiscal 2023.
- X4 PHARMACEUTICALS, INC payments to acquire productive assets for fiscal 2023 was $60.00K, a 41.75% decline from fiscal 2022.
- X4 PHARMACEUTICALS, INC payments to acquire productive assets for fiscal 2022 was $103.00K, a 83.25% decline from fiscal 2021.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 9 month as first filed | Payments to Acquire Productive Assets 12 month | Payments to Acquire Productive Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $0.00 derived: sum of 3 quarters · filed 2026-03-17 | $0.00 10-K · filed 2026-03-17 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $41.00K derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $41.00K derived: sum of 3 quarters · filed 2026-03-17 | $133.00K derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-01 | $41.00K derived: sum of 2 quarters · filed 2026-03-17 | $133.00K derived: sum of 3 quarters · filed 2026-03-17 | $267.00K derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2024-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $133.00K derived: sum of 2 quarters · filed 2026-03-17 | $267.00K derived: sum of 3 quarters · filed 2026-03-17 | $326.00K 10-K · filed 2026-03-17 | ||
| 2024-09-30 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $226.00K derived: sum of 2 quarters · filed 2025-11-05 | $285.00K 10-Q · filed 2025-11-05 | $320.00K derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2024-06-30 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $193.00K 10-Q · filed 2025-08-08 | $228.00K derived: sum of 3 quarters · filed 2026-03-17 | $236.00K derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2024-03-31 | $59.00K 10-Q · filed 2025-05-01 | $94.00K derived: sum of 2 quarters · filed 2026-03-17 | $102.00K derived: sum of 3 quarters · filed 2026-03-17 | $110.00K derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2023-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $43.00K derived: sum of 2 quarters · filed 2026-03-17 | $51.00K derived: sum of 3 quarters · filed 2026-03-17 | $60.00K 10-K · filed 2026-03-17 | ||
| 2023-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $16.00K derived: sum of 2 quarters · filed 2024-11-13 | $25.00K 10-Q · filed 2024-11-13 | $59.00K derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $17.00K 10-Q · filed 2024-08-08 | $51.00K derived: sum of 3 quarters · filed 2024-08-08 | $60.00K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $9.00K 10-Q · filed 2024-05-07 | $43.00K derived: sum of 2 quarters · filed 2024-05-07 | $52.00K derived: sum of 3 quarters · filed 2024-05-07 | $90.00K derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $43.00K derived: sum of 2 quarters · filed 2024-03-21 | $81.00K derived: sum of 3 quarters · filed 2024-03-21 | $103.00K 10-K · filed 2024-03-21 | ||
| 2022-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $47.00K derived: sum of 2 quarters · filed 2023-11-09 | $69.00K 10-Q · filed 2023-11-09 | $82.00K derived: sum of 4 quarters · filed 2024-03-21 | ||
| 2022-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $60.00K 10-Q · filed 2023-08-10 | $73.00K derived: sum of 3 quarters · filed 2024-03-21 | $93.00K derived: sum of 4 quarters · filed 2024-03-21 | ||
| 2022-03-31 | $22.00K 10-Q · filed 2023-05-04 | $35.00K derived: sum of 2 quarters · filed 2024-03-21 | $55.00K derived: sum of 3 quarters · filed 2024-03-21 | $141.00K derived: sum of 4 quarters · filed 2024-03-21 | ||
| 2021-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $33.00K derived: sum of 2 quarters · filed 2024-03-21 | $119.00K derived: sum of 3 quarters · filed 2024-03-21 | $615.00K 10-K · filed 2024-03-21 | ||
| 2021-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $106.00K derived: sum of 2 quarters · filed 2022-11-03 | $602.00K 10-Q · filed 2022-11-03 | $904.00K derived: sum of 4 quarters · filed 2023-03-21 | ||
| 2021-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $582.00K 10-Q · filed 2022-08-04 | $884.00K derived: sum of 3 quarters · filed 2023-03-21 | $1.38M derived: sum of 4 quarters · filed 2023-03-21 | ||
| 2021-03-31 | $496.00K 10-Q · filed 2022-05-12 | $798.00K derived: sum of 2 quarters · filed 2023-03-21 | $1.29M derived: sum of 3 quarters · filed 2023-03-21 | $1.30M derived: sum of 4 quarters · filed 2023-03-21 | ||
| 2020-12-31 | $302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | $798.00K derived: sum of 2 quarters · filed 2023-03-21 | $807.00K derived: sum of 3 quarters · filed 2023-03-21 | $1.36M 10-K · filed 2023-03-21 | ||
| 2020-09-30 | $496.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $505.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.06M 10-Q · filed 2021-11-04 | $1.14M derived: sum of 4 quarters · filed 2022-03-17 | ||
| 2020-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $564.00K 10-Q · filed 2021-08-03 | $647.00K derived: sum of 3 quarters · filed 2022-03-17 | $728.00K derived: sum of 4 quarters · filed 2022-03-17 | ||
| 2020-03-31 | $555.00K 10-Q · filed 2021-05-06 | $638.00K derived: sum of 2 quarters · filed 2022-03-17 | $719.00K derived: sum of 3 quarters · filed 2022-03-17 | $729.00K derived: sum of 4 quarters · filed 2022-03-17 | ||
| 2019-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $164.00K derived: sum of 2 quarters · filed 2022-03-17 | $174.00K derived: sum of 3 quarters · filed 2022-03-17 | $174.00K 10-K · filed 2022-03-17 | ||
| 2019-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $91.00K derived: sum of 2 quarters · filed 2020-11-05 | $91.00K 10-Q · filed 2020-11-05 | $91.00K derived: sum of 4 quarters · filed 2021-03-19 | ||
| 2019-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $10.00K 10-Q · filed 2020-08-04 | $10.00K derived: sum of 3 quarters · filed 2021-03-19 | -$17.00K derived: sum of 4 quarters · filed 2021-03-19 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-03-19 | -$27.00K derived: sum of 3 quarters · filed 2021-03-19 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | -$27.00K derived: sum of 2 quarters · filed 2021-03-19 | $0.00 10-K · filed 2021-03-19 | $34.00K 10-K · filed 2019-03-11 | ||
| 2018-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $34.00K 10-Q · filed 2018-11-09 | |||
| 2018-06-30 | $27.00K 10-Q · filed 2018-08-13 | |||||
| 2017-12-31 | $319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $337.00K derived: sum of 2 quarters · filed 2020-03-12 | $361.00K derived: sum of 3 quarters · filed 2020-03-12 | $378.00K 10-K · filed 2020-03-12 | $42.00K 10-K · filed 2019-03-11 | |
| 2017-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $42.00K derived: sum of 2 quarters · filed 2018-11-09 | $59.00K 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $41.00K 10-Q · filed 2018-08-13 | ||||
| 2017-03-31 | $17.00K 10-Q · filed 2018-05-10 | |||||
| 2016-12-31 | $73.00K 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |